SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Wang Theodore T, et al. – ‘4’ for 10/13/23 re: Bellerophon Therapeutics, Inc.

On:  Monday, 10/16/23, at 8:51pm ET   ·   For:  10/13/23   ·   As:  10% Owner   ·   Accession #:  1760460-23-8   ·   File #:  1-36845

Previous ‘4’:  ‘4’ on 6/30/23 for 6/29/23   ·   Latest ‘4’:  This Filing

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

10/16/23  Wang Theodore T                   4          10% Owner   1:9K   Bellerophon Therapeutics, Inc.    Puissance Life Scien… VI
          Puissance Capital Management LP
          Puissance Life Science Opportunities Fund VI
          Puissance Capital Fund (GP) LLC

Statement of Changes in Beneficial Ownership of Securities by an Insider   —   Form 4   —   SEA’34

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 4           Statement of Changes in Beneficial Ownership of     HTML      9K 
                Securities by an Insider -- primary_doc.xml/5.8                  




        

This ‘4’ Document is an XML Data File that may be rendered in various formats:

  Form 4    –   Plain Text   –  SEC Website  –  EDGAR System  –    XML Data    –  <?xml?> File
 

 
SEC Info rendering:  Statement of Changes in Beneficial Ownership of Securities by an Insider
 

The SEC has not released XSLT Stylesheets needed to render this File’s XML Data as a Form.

This is our “Plain Text” rendering:
 
                                                                                                                                                                                
Ownership Document
 
Schema Version:  X0508
Document Type:  4
Period of Report:  10/13/23
Not Subject to Section 16:  1
Issuer:
Issuer CIK:  1600132
Issuer Name:  Bellerophon Therapeutics, Inc.
Issuer Trading Symbol:  BLPH
Reporting Owner:
Reporting Owner ID:
Owner CIK:  1658437
Owner Name:  Puissance Capital Management LP
Reporting Owner Address:
Owner Street 1:  45 E 85TH ST
Owner Street 2:  5A
Owner City:  NEW YORK
Owner State:  NY
Owner ZIP Code:  10028
Owner State Description:
Reporting Owner Relationship:
Is Director?  No
Is Officer?  No
Is Ten Percent Owner?  Yes
Is Other?  No
Reporting Owner:
Reporting Owner ID:
Owner CIK:  1760460
Owner Name:  Puissance Life Science Opportunities Fund VI
Reporting Owner Address:
Owner Street 1:  950 THIRD AVENUE
Owner Street 2:  FL 25
Owner City:  NEW YORK
Owner State:  NY
Owner ZIP Code:  10022
Owner State Description:
Reporting Owner Relationship:
Is Director?  No
Is Officer?  No
Is Ten Percent Owner?  Yes
Is Other?  No
Reporting Owner:
Reporting Owner ID:
Owner CIK:  1695347
Owner Name:  Puissance Capital Fund (GP) LLC
Reporting Owner Address:
Owner Street 1:  950 THIRD AVENUE
Owner Street 2:  25TH FLOOR
Owner City:  NEW YORK
Owner State:  NY
Owner ZIP Code:  10022
Owner State Description:
Reporting Owner Relationship:
Is Director?  No
Is Officer?  No
Is Ten Percent Owner?  Yes
Is Other?  No
Reporting Owner:
Reporting Owner ID:
Owner CIK:  1694061
Owner Name:  Wang Theodore T
Reporting Owner Address:
Owner Street 1:  C/O PUISSANCE CAPITAL MANAGEMENT LP
Owner Street 2:  950 THIRD AVENUE, 25TH FLOOR
Owner City:  NEW YORK
Owner State:  NY
Owner ZIP Code:  10022
Owner State Description:
Reporting Owner Relationship:
Is Director?  No
Is Officer?  No
Is Ten Percent Owner?  Yes
Is Other?  No
Aff 10b5 One:  0
Non-Derivative Table:
Non-Derivative Transaction:
Security Title:
Value:  Common Stock
Transaction Date:
Value:  10/13/23
Transaction Coding:
Transaction Form Type:  4
Transaction Code:  S
Equity Swap Involved?  No
Transaction Timeliness:
Value:
Transaction Amounts:
Transaction Shares:
Value:  1,076,841
Transaction Price Per Share:
Value:  0.1038
Transaction Acquired-Disposed Code:
Value:  D
Post-Transaction Amounts:
Shares Owned Following Transaction:
Value:  0
Ownership Nature:
Direct or Indirect Ownership:
Value:  D
Remarks:  These securities are held directly by Puissance Life Science Opportunities Fund VI and may be deemed to be beneficially owned by Puissance Capital Management LP, the investment manager of Puissance Life Science Opportunities Fund VI; Puissance Capital Fund(GP) LLC, the general partner of Puissance Capital Management LP; Puissance Capital Fund (GP) LLC, the general partner of Puissance Life Science Opportunities Fund VI; and Theodore T. Wang, the managing member of Puissance Capital Management (GP) LLC and Puissance Capital Fund (GP) LLC. The Reporting Persons each disclaim beneficial ownership of the reported securities except to the extent of its pecuniary interest therein. This report shall not be deemed an admission that any Reporting Person is the beneficial owner of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.
Owner Signature:
Signature Name:  Puissance Life Science Opportunities Fund VI, By: Puissance Capital Fund (GP) LLC, its managing member, By: Theodore T. Wang, Managing Member
Signature Date:  10/16/23
Owner Signature:
Signature Name:  Puissance Capital Fund (GP) LLC, By: Theodore T. Wang, Managing Member
Signature Date:  10/16/23
Owner Signature:
Signature Name:  Puissance Capital Management LP, By: Puissance Capital Fund (GP) LLC, its general partner, By: Theodore T. Wang, Managing Member
Signature Date:  10/16/23
Owner Signature:
Signature Name:  /s/ Theodore T. Wang
Signature Date:  10/16/23


Top
Filing Submission 0001760460-23-000008   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Sun., May 12, 12:59:50.1am ET